Impact of old age, comorbidity, and polypharmacy on adjuvant endocrine therapy for patients with early-stage breast cancer.
OBJECTIVES To explore effects of adjuvant endocrine therapy (ET) among women with early-stage hormone receptor positive breast cancer aged 70+ years, with comorbidities or experiencing polypharmacy. METHODS Women diagnosed with breast cancer in 2006-2022 were identified from the Te Rēhita Mate Ūtaetae - Breast Cancer...